HOME >> MEDICINE >> NEWS
Rochester study shows ethnic disparities in medicare claims

African Americans and Latinos are more likely to underestimate how long it has been since their last routine screening test for disease -- such as a mammogram, Pap smear, or cholesterol test according to a University of Rochester study that matched patient recollections with Medicare documentation. Researchers are concerned this might be harming the health of minorities in the long run.

"If you ask anyone, "When was the last time you had a mammogram, or a cholesterol test?' almost all people will think it's been a shorter time than it's actually been. Over-reporting happens to all of us," said lead author Kevin Fiscella, M.D., M.P.H. "But our study found that some minorities tend to over-report even more often than other groups of patients. This is a problem that has to be recognized and fixed."

Fiscella, an associate professor of Family Medicine and Community and Preventive Medicine at the University of Rochester Medical Center, said he is not sure why the discrepancy in reporting exists. One theory supported by social psychology research is that African American or Latino patients may feel some pressure to defy stereotypes. So, when doctors or nurses ask them about an event for which they are uncertain, they err on the side of caution and reply affirmatively, he said.

The study is to be published Sept. 29, 2006, in the open access journal BMC Health Services Research.

The University of Rochester collaborated with colleagues from the University of California in Sacramento to analyze 49,645 patient records, matching Medicare claims with patient surveys of the last preventive screening test they had received. The researchers made statistical adjustments for age, gender, income, education level and health status.

With the exception of PSA testing for prostate cancer, results showed that minority patients were more likely to report taking part in a test in the absence of a submitted Medicare claim. In addition to over-re
'"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
29-Sep-2006


Page: 1 2

Related medicine news :

1. Rochester spreads knowledge of cancer-related fatigue
2. Rochester study rolls out RU-486 to treat uterine fibroids
3. University of Rochester spin-off secures $2 million in funding
4. Rochester researchers join federal initiative to improve drug safety
5. Rochester launches Cancer Stem Cell Research Program
6. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. New study shows promise in reducing surgical risks associated with surgical bleeding
9. New study counts the economic cost of persistent pain in Australia
10. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
11. Most seniors now have drug coverage, U-M study shows

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rochester study shows ethnic disparities medicare claims

(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: